These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 33544910)

  • 21. Effectiveness of Convalescent Plasma Therapy in Treating COVID-19: an Evidence-based Case Report.
    Yulianti M; Johan C; Singh G; Tenda ED; Herikurniawan H; Wijaya IPEK
    Acta Med Indones; 2021 Oct; 53(4):497-504. PubMed ID: 35027500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Convalescent Plasma for Pregnant Women with COVID-19: A Systematic Literature Review.
    Franchini M; Prefumo F; Grisolia G; Bergamini V; Glingani C; Pisello M; Presti F; Zaffanello M
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34206468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of convalescent plasma for the treatment of severe influenza.
    Xu Z; Zhou J; Huang Y; Liu X; Xu Y; Chen S; Liu D; Lin Z; Liu X; Li Y
    Crit Care; 2020 Jul; 24(1):469. PubMed ID: 32727526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis.
    Abeldaño Zuñiga RA; González-Villoria RAM; Elizondo MV; Osorio AYN; Martínez DG; Coca SM
    Ther Adv Respir Dis; 2021; 15():17534666211028077. PubMed ID: 34190621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.
    Peng HT; Rhind SG; Beckett A
    JMIR Public Health Surveill; 2021 Apr; 7(4):e25500. PubMed ID: 33825689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there any potential management against COVID-19? A systematic review and meta-analysis.
    Talaie H; Hosseini SM; Nazari M; Fakhri Y; Mousavizadeh A; Vatanpour H; Firoozfar A
    Daru; 2020 Dec; 28(2):765-777. PubMed ID: 32812187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of COVID-19 Treatment Using Convalescent Plasma Transfusion: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Lee HJ; Lee JH; Cho Y; Ngoc LTN; Lee YC
    Int J Environ Res Public Health; 2022 Aug; 19(17):. PubMed ID: 36078338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial.
    Chowdhury FR; Hoque A; Chowdhury FUH; Amin MR; Rahim A; Rahman MM; Yasmin R; Amin MR; Miah MT; Kalam MA; Rahman MS
    Trials; 2020 Oct; 21(1):883. PubMed ID: 33106167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
    Wooding DJ; Bach H
    Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study.
    Abolghasemi H; Eshghi P; Cheraghali AM; Imani Fooladi AA; Bolouki Moghaddam F; Imanizadeh S; Moeini Maleki M; Ranjkesh M; Rezapour M; Bahramifar A; Einollahi B; Hosseini MJ; Jafari NJ; Nikpouraghdam M; Sadri N; Tazik M; Sali S; Okati S; Askari E; Tabarsi P; Aslani J; Sharifipour E; Jarahzadeh MH; Khodakarim N; Salesi M; Jafari R; Shahverdi S
    Transfus Apher Sci; 2020 Oct; 59(5):102875. PubMed ID: 32694043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Convalescent plasma is a clutch at straws in COVID-19 management! A systematic review and meta-analysis.
    Sarkar S; Soni KD; Khanna P
    J Med Virol; 2021 Feb; 93(2):1111-1118. PubMed ID: 32776573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
    Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study.
    Wu Y; Hong K; Ruan L; Yang X; Zhang J; Xu J; Pan S; Ren L; Chen L; Huang C; Shang Y
    Virol Sin; 2020 Dec; 35(6):768-775. PubMed ID: 32865701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Convalescent plasma for COVID-19 in the intensive care unit.
    Rollas K; Emgin Ö; Çalışkan T; K Güldoğan I; Zincircioğlu Ç; Ersan G; Sahar İ; Sarıtaş A; Uzun U; Senoğlu N
    Anaesthesiol Intensive Ther; 2021; 53(5):398-402. PubMed ID: 35100797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial.
    Bégin P; Callum J; Jamula E; Cook R; Heddle NM; Tinmouth A; Zeller MP; Beaudoin-Bussières G; Amorim L; Bazin R; Loftsgard KC; Carl R; Chassé M; Cushing MM; Daneman N; Devine DV; Dumaresq J; Fergusson DA; Gabe C; Glesby MJ; Li N; Liu Y; McGeer A; Robitaille N; Sachais BS; Scales DC; Schwartz L; Shehata N; Turgeon AF; Wood H; Zarychanski R; Finzi A; ; Arnold DM
    Nat Med; 2021 Nov; 27(11):2012-2024. PubMed ID: 34504336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report.
    Omrani AS; Zaqout A; Baiou A; Daghfal J; Elkum N; Alattar RA; Bakdach D; Abusriwil H; Mostafa AM; Alhariri B; Ambra N; Khatib M; Eldeeb AM; Merenkov Z; Fawzi Z; Hmissi SM; Hssain AA; Coyle PV; Alsoub H; Almaslamani MA; Alkhal A
    J Med Virol; 2021 Mar; 93(3):1678-1686. PubMed ID: 32965715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Transfusion of convalescent plasma from patients with COVID -19].
    Galván CA; Toribio-Dionicio C; Álvarez-Ángeles M; Alama-Bazán O; Sánchez-Ramírez L
    Rev Peru Med Exp Salud Publica; 2020; 37(4):746-754. PubMed ID: 33566918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized placebo-controlled trial of convalescent plasma for adults hospitalized with COVID-19 pneumonia.
    Thorlacius-Ussing L; Brooks PT; Nielsen H; Jensen BA; Wiese L; Sækmose SG; Johnsen S; Gybel-Brask M; Johansen IS; Bruun MT; Stærke NB; Østergaard L; Erikstrup C; Ostrowski SR; Homburg KM; Georgsen J; Mikkelsen S; Sandholdt H; Leding C; Hovmand N; Clausen CL; Tinggaard M; Pedersen KBH; Iversen KK; Tingsgård S; Israelsen SB; Benfield T
    Sci Rep; 2022 Sep; 12(1):16385. PubMed ID: 36180450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.